Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)

Taiwan · Delayed Price · Currency is TWD

80.20

-0.70 (-0.87%)

Sep 24, 2026, 1:30 PM CST

Foresee Pharmaceuticals Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	471.13	431.27	418.69	195.04	301.51	226.03
Revenue Growth	6.41%	3.01%	114.67%	-35.31%	33.39%	-1.91%
Gross Profit	366.08	294.22	239.8	113.97	275.97	175.08
Operating Income	-492.31	-862.32	-1,080	-1,008	-469.44	-538.63
Net Income	22.5	-883.15	-1,081	-1,036	-472.64	-569.27
Earnings Per Share	0.14	-5.70	-7.87	-8.14	-4.00	-4.85
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	220.23	272.75	409.87	193.95	201.34
Europe	-	46.1	2.59	0.08	39.59
China	-	112.42	6.23	1.01	60.58
Total	471.13	431.27	418.69	195.04	301.51

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	910.92	479.52	1,367	1,160	689.51	1,269
Total Debt	398.33	231.74	260.33	228.26	41.32	16.65
Net Cash (Debt)	512.58	247.78	1,107	931.42	648.19	1,252
Net Cash Growth	-16.85%	-77.62%	18.85%	43.70%	-48.24%	-16.05%
Net Cash Per Share	3.25	1.60	8.06	7.32	5.49	10.67

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-545.15	-842.23	-1,174	-887.56	-233.22	-213.33
Capital Expenditures	-47.85	-2.96	-149.59	-46.28	-58.07	-6.86
Free Cash Flow	-593.01	-845.19	-1,323	-933.84	-291.29	-220.19
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	77.70%	68.22%	57.27%	58.44%	91.53%	77.46%
Operating Margin	-104.50%	-199.95%	-257.90%	-516.63%	-155.70%	-238.30%
Pretax Margin	18.94%	-198.99%	-246.77%	-506.89%	-145.31%	-233.59%
Profit Margin	4.78%	-204.78%	-258.20%	-531.33%	-156.76%	-251.86%
FCF Margin	-125.87%	-195.98%	-316.07%	-478.80%	-96.61%	-97.42%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	53.91	53.91	53.91	53.91	53.91
PS Ratio	26.82	29.44	28.65	66.97	35.81	62.15